Podcasts about wills eye hospital

What are the real-world safety data following administration of faricimab (Vabysmo, Genentech)? Maura Di Nicola, MD, and guests Sruthi Arepalli, MD, and Barton Blackorby, MD, review data from a real-world, single-center, retrospective study of approximately 4500 injections of faricimab in over 700 patients at Wills Eye Hospital. What did the data show? And do these data effect the clinical patterns of Drs. Di Nicola, Arepalli, and Blackorby? 

Sunir J. Garg, MD is a Professor of Ophthalmology at Wills Eye Hospital in Philadelphia and a clinical spokesperson for the American Academy of Ophthalmology. His clinical interests include advanced treatments for diabetic retinopathy, age-related macular degeneration, complex retinal detachments, retinal vascular diseases, and surgical diseases of the macula and retina. In addition to authoring over 500 papers and book chapters, Dr. Garg serves as an editor for the Merck Manual, Editor-in-Chief of the American Academy of Ophthalmology ONE Network, and is on the American Diabetes Association Standard of Care Committee. https://www.seniorcareauthorit... For people in need of an eye exam but are worried about the cost, they should check if they qualify for a free exam with EyeCare America. This program offers comprehensive eye exams with volunteer ophthalmologists at little or no cost to the patient. People can check if they or a loved one qualifies at EyeCareAmerica.org

In this week's episode, our medical student host interviews Dr. JP Dunn, a uveitis specialist at Wills Eye Hospital. He teaches us about uveitis, ocular inflammation, and the delivery of multidisciplinary care within uveitis. After listening to this episode, you will have a better understanding of how to approach a patient presenting to clinic with ocular inflammation and the different conditions seen by a uveitis specialist.

If you're an ASOPRS Member, Surgeon or Trainee and are interesting in hosting a podcast episode, please submit your idea by visiting: asoprs.memberclicks.net/podcast About the Guest(s): Dr. Ken Morgenstern is a renowned Oculofacial Plastic and Reconstructive Surgeon in private practice in Philadelphia, Pennsylvania. He is also an Associate Professor at Wills Eye Hospital and Thomas Jefferson University. In 2024, Dr. Morgenstern served as the President of the American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS). His distinguished career includes significant contributions to the field of oculofacial plastic surgery, as well as active involvement in the governance and policy-making aspects of ASOPRS. Dr. Grant Moore is an oculofacial plastic surgeon in Phoenix and Scottsdale, Arizona. He is an Assistant Clinical Professor of Ophthalmology and Oral-Maxillofacial Surgery at the University of Arizona College of Medicine. He is the chair of the ASOPRS Podcast Workgroup. Episode Summary: In this milestone 50th episode of The Oculofacial Podcast, host Dr. Grant Moore, an oculofacial plastic surgeon in Phoenix and Scottsdale, Arizona interviews Dr. Ken Morgenstern, the outgoing President of ASOPRS. The episode features a discussion with Dr. Morgenstern about his tenure as ASOPRS president in 2024. Dr. Morgenstern delves into the achievements and challenges of his presidential term, including advocacy for a more comprehensive board certification process and the creation of an effective and equitable conflict of interest policy for ASOPRS board members. He also covers the significance of diversity and open dialogue in shaping organizational policies and propelling progressive transition within the society. Key Takeaways: · Leadership and Vision: Dr. Morgenstern spotlights major developments during his tenure, including enhanced board certification efforts and development of a conflict of interest policy. · Advocacy and Representation: Insights into the need for greater advocacy for oculofacial surgeons to ensure fair practices and adequate representation in broader medical contexts. · Strategic Transformation: Emphasizing the importance of adaptability and embracing change to maintain relevance and efficacy within professional societies. · Community and Education: Dr. Morgenstern stresses continued education for members on complex issues and fostering volunteerism for the society's growth. Notable Quotes: 1. "Board certification is essential for our advocacy, giving us a voice and recognition in the medical community." 2. "Embracing diverse perspectives really strengthens the decision-making process and our society's evolution." 3. "Persistence in getting involved and learning through various committees has been key to my professional growth." Explore more on the transformation and upcoming initiatives in the oculofacial community by listening to the full episode. Stay connected for more enlightening discussions and insights by subscribing to the "Oculofacial Podcast."

I first met Dr Nicole Fram almost 20 years ago when she was a resident at Wills Eye Hospital in Philadelphia, USA. I was there giving a series of lectures as a visiting professor in their department and was impressed with Dr Fram and her co-residents. In the past two decades Dr Fram has cemented her role as an expert with complex re-operations where patients need an IOL exchange or anterior segment reconstruction. She is in the Los Angeles area and I am fortunate to be one of her partners in our large Beverly Hills surgery center. I am confident that you will enjoy this podcast and even learn some great pearls in dealing with challenging patients and cases. We feature a new podcast every week on Sundays and they are uploaded to all major podcast services (click links here: Apple, Google, Spotify) for enjoying as you drive to work or exercise. I am really excited to share these amazing podcasts with you. The full video of the podcast is here on CataractCoach as well as on our YouTube channel. For 2024 our podcast is sponsored by Harrow, Inc and we are thankful for their support. One more Harrow sponsored podcast is coming next Sunday and then their turn comes to an end. If you would like to learn about sponsoring the top podcast in ophthalmology, please reach out. 

If you're an ASOPRS Member, Surgeon or Trainee and are interesting in hosting a podcast episode, please submit your idea by visiting: asoprs.memberclicks.net/podcast About the Hosts Daniel J. Ozzello, MD - Dr. Daniel J. Ozzello is a dedicated faculty member in the Division of Oculoplastics at the University of Colorado. With a rich background that includes training in ophthalmology at the Wills Eye Hospital and an ASOPRS fellowship in San Diego under the esteemed Dr. Don Kikkawa and Dr. Bobby Korn, Dr. Ozzello has established a diverse practice in oculoplastics as well as urgent and inpatient ophthalmic care. At Colorado, he engages in clinical care, research and teaching. Caroline Vloka, MD - Dr. Caroline Vloka recently completed her fellowship at the University of Colorado following her residency in Pittsburgh. Bringing fresh perspectives and insights, she has already made a substantial impact as a new faculty member. Her interests lie in advancing oculoplastic surgery techniques and patient outcomes, carrying forward her rigorous training and passion for patient care. Episode Summary: In this informative episode of the OculoFacial Podcast, Dr. Daniel J. Ozzello teams up with Dr. Caroline Vloka to delve into the latest advancements in oculoplastic surgery, focusing on two significant blepharoplasty studies. The discussion revolves around the effectiveness of tranexamic acid (TXA) in surgery, alongside an exploration of the cost-effectiveness of these surgical interventions and their impacts on patient care. Introducing listeners to these critical insights, the duo unpacks recent research findings, igniting conversations on how these might enhance surgical practices and patient outcomes. The analysis begins with an examination of a study concerning the preoperative use of TXA in eyelid surgery, meant to reduce bruising and improve patient satisfaction. Highlighting its potential benefits, Dr. Ozzello and Dr. Vloka weigh the simplicity and cost-effectiveness of incorporating TXA into regular surgical protocols. The conversation then shifts towards evaluating the economic and quality-of-life impacts that blepharoplasty offers. The pair discuss a study that aligns the procedure with high cost-effectiveness scores, emphasizing its beneficial role in elevating patient functioning and wellbeing. Key Takeaways: Tranexamic Acid Efficacy: Recent studies demonstrate that tranexamic acid significantly reduces bruising and enhances patient satisfaction in blepharoplasty procedures. Oculoplastics Cost-Effectiveness: Blepharoplasty is proven to be highly cost-effective, providing substantial improvements in quality of life for patients with dermatochalasis Importance of Context: The subjective nature of cosmetic and functional outcomes can vary based on demographic factors and patient profiles. Thorough Patient Education: Managing patient expectations about postoperative outcomes is crucial for satisfaction, especially when comparing with other surgeries like cataract interventions. Collaborative Inquiry: There is a call for larger-scale studies and collaborative data pooling in oculoplastic research to better address rare conditions like idiopathic orbital myositis Resources: University of Colorado - Division of Oculoplastics: Official Website Publications on Tranexamic Acid and Blepharoplasty: Recent articles in OPRS (Oculoplastic and Reconstructive Surgery). Listen to the full episode for valuable insights and stay tuned for more enlightening and engaging content from the OculoFacial Podcast!  

Dr. Marc Spirn from Wills Eye Hospital discusses the results of a retrospective study of performing lattice degeneration on a series of patients who had lattice degeneration with high risk features.   The discussed article: Kazan AS, Mahmoudzadeh R, Salabati M, Sharpe J, Fineman MS, Hsu J, Yonekawa Y, Spirn MJ. Indications and Outcomes of Laser Retinopexy in Eyes With High-Risk Lattice Degeneration. J Vitreoretin Dis. 2024 Apr 25;8(4):381-387. doi: 10.1177/24741264241248253. PMID: 39148566; PMCID: PMC11323511.

In this video, Dr. Shields reveals the truth about pediatric and pregnancy ocular melanoma. Learn more about this rare form of cancer and how it can be treated. Dr. Shields reveals the truth about pediatric & pregnancy ocular melanoma in this informative video. Learn all about uveal melanoma from the expert!In this video, Dr. Shields reveals the truth about pediatric and pregnancy ocular melanoma. Learn more about this rare eye cancer.In this video, Dr. Shields reveals the truth about pediatric and pregnancy ocular melanoma. Learn more about this rare eye cancer.In this powerful episode of the Eye Believe Podcast, I'm joined by the renowned Dr. Carol Shields from Wills Eye Hospital to tackle some of the most common myths surrounding pediatric ocular melanoma and pregnancy-related ocular melanoma. Dr. Shields, an expert in ocular oncology, provides critical insights into the realities of these rare conditions and offers hope and clarity to those affected.In this episode, we cover:Myth-busting the risks of ocular melanoma in children.The truth about pregnancy and ocular melanoma: Does it increase the risk?Cutting-edge treatments for pediatric patients and expectant mothers.How early detection and genetic testing are transforming outcomes.Real-life patient stories that bring hope to families.Whether you or a loved one has been impacted by ocular melanoma or you're just looking for the facts, this conversation is a must-watch. Dr. Shields not only separates fact from fear but also shines a light on the future of treatment for children and young mothers.Don't forget to like, share, and subscribe for more episodes that dive deep into the latest in cancer research, treatments, and patient stories.

Dr. Natasha Nayak Kolomeyer, a glaucoma specialist and ophthalmologist at Wills Eye Hospital, discusses various types of eye drops used in glaucoma treatment, how they work, potential side effects, and tips for managing challenges associated with their use. We'll also discuss new developments in glaucoma eye drops and how long these treatments are required.

In this episode, we dive deep into the revolutionary role of AI in clinical trials and patient care with George Magrath, MD, an esteemed ophthalmologist and the CEO of a cutting-edge pharmaceutical company specializing in ophthalmic drug development. Dr. Magrath shares his expertise, having trained in ocular oncology at the renowned Wills Eye Hospital in Philadelphia. Dr. Magrath shares the innovative ways AI is being used in clinical trials, from patient selection to the development of new eye care medications. He also discusses how AI can accelerate the availability of effective ocular treatments and address wealth inequality in US health care. Lastly, we'll look ahead to the future prospects of AI in transforming ophthalmic pharmaceutical developments. Tune in to discover how AI is reshaping the landscape of eye care and improving patient outcomes! The Four Eyes Podcast is brought to you by YoungOD Connect Learn more about Dr. Magrath Learn more about companies using revolutionary AI technology in the medical space: Voxeleron, Verana Health, RETINA-AI

We review the 6 month results of the Davio 2 trial of  the Durayvu TKI delivery system for maintenance therapy of neovascular AMD with Dr. Carl Regillo of Wills Eye Hospital.

EN: In this episode of Seeing Clearly, Mohamed Gemae and Anas Abu-Dieh (two Eye Curriculum Ambassadors) talk to Dr. Paul Harasymowycz, glaucoma specialist at Université de Montréal and McGill University. This is the first episode of our french mini-series (“Vision Claire”).   Dr. Paul Harasymowycz is a fellowship-trained glaucoma specialist at “Ophtalmologie Bellevue” and “L'Institut de Glaucome de Montréal”. He is an associate professor in the Department of Ophthalmology at Université de Montréal and was recently appointed as an associate professor in the Department of Ophthalmology & Visual Sciences (DOVS) at McGill University. Dr. Harasymowycz obtained his fellowship in glaucoma from Wills Eye Hospital in Philadelphia after completing his medical school at McGill and his residency in ophthalmology at Université de Montréal.   Dr. Harasymowycz is a clinician scientist whose research focuses on raising awareness on the importance of early screening of glaucoma in at-risk populations. In addition, he is often invited to present and teach new surgical techniques at national and international conferences, and he is one of the pioneers of microinvasive glaucoma surgery (MIGS). He contributes significantly to teaching clerks, residents, and fellows about these innovative techniques.   In addition to his impressive academic portfolio, Dr. Harasymowycz is also the founder and medical director of the “Ophtalmologie Bellevue” clinics. Finally, he is the author of “Le Glaucome”, one of the only glaucoma books written in French aimed at educating patients about their condition.   In this episode, we discuss: - Dr. Harasymowycz's unique journey to and within ophthalmology - What a “Day in the Life” looks like for Dr. Harasymowycz - What inspired him to write his book, “Le Glaucome” - Advice for learners (medical students and residents) - His favorite musician!   Check out our website: www.eyecurriculum.com Follow us on Instagram: www.instagram.com/EyeCurriculum Follow us on Twitter: www.twitter.com/EyeCurriculum FR: Dans cet épisode de Seeing Clearly, Mohamed Gemae et Anas Abu-Dieh (ambassadeurs de Eye Curriculum) discutent avec le Dr. Paul Harasymowycz, un spécialiste en glaucome à l'Université de Montréal et à l'Université McGill. Ceci est le premier épisode de la mini-série Francophone, “Vision Claire”. Dr. Paul Harasymowycz est un spécialiste en glaucome, fondateur et directeur médical aux cliniques d'Ophtalmologie Bellevue et à l'Institut de Glaucome de Montréal. Il est professeur associé au Département d'Ophtalmologie à l'Université de Montréal et récemment au Département d'Ophtalmologie et des Sciences Visuelles à McGill. Le Dr. Harasymowycz a complété son fellowship au Wills Eye Hospital en Philadelphie après avoir complété ses études en médecine à McGill et sa résidence en ophtalmologie à l'Université de Montréal. Dr. Harasymowycz est un clinicien chercheur qui concentre ses efforts sur le glaucome et la sensibilisation de la population afin d'encourager les personnes à risque d'effectuer un dépistage précoce. De plus, il est souvent invité à présenter et enseigner les nouvelles techniques et traitements chirurgicaux à des congrès nationaux et internationaux, et est un des pionniers des chirurgies micro-invasives en glaucome (MIGS). Expert et passionné, il enseigne à des externes, des résidents, des fellows, et autres professionnels de la santé. En plus de son portfolio académique impressionnant, Dr. Harasymowycz est auteur du livre « Le Glaucome », qui est un des seuls livres français destinés à la population générale, avec le but de créer une ressource éducative additionnelle pour ses patients. Dans cet épisode, nous abordons :     - Le parcours unique du Dr Harasymowycz en ophtalmologie - À quoi ressemble une "Journée dans la vie" du Dr Harasymowycz  - L'inspiration derrière son livre "Le Glaucome" - Des conseils pour les étudiants en médecine/résidents - Son musicien préféré!

Hosts Jim Mazzo and John A. Hovanesian, MD, FACS, chat with Julia Haller, MD, about the latest developments in retina, residency training and more. Welcome to the Eyeluminaries podcast :01 Review of episode 17, live from Octane OTF :41 Bausch + Lomb makes a number of big moves under the new Brent Saunders regime 1:40 Mark Baum and Harrow Health have also been making a number of acquisitions 3:59 FDA approves Xdemvy for Demodex blepharitis treatment 5:45 Former CEO of Johnson & Johnson Alex Gorsky elected lead director of Neurotech's board 7:47 John begins new clinical committee for ASCRS, digital 9:32 Julia Haller, MD introduction 11:30 ReST Committee update on intraocular inflammation reported in patients who received Syfovre at the American Society of Retina Specialists annual meeting 13:44 The FDA approved Izervay for the treatment of geographic atrophy secondary to age-related macular degeneration, according to a press release from Astellas Pharma 14:16 Novartis is discontinuing the development of GT005 for the treatment of geographic atrophy secondary to dry age-related macular degeneration 14:36 How has the latest retina news affected patients and physicians? 14:53 The development of biosimilars 19:50 Discussion on pricing of products 21:57 The evolution and future of residency programs 23:34 Fun with retina drug names 27:15 Preview of episode 19 at OSN New York 29:46 Feedback, questions and guest suggestions at eyeluminaries@healio.com 30:15 Thanks for listening 30:27 John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/Chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA. Julia Haller, MD, is Ophthalmologist-in-Chief and William Tasman, MD Endowed Chair at Wills Eye Hospital and Professor and Chair of Ophthalmology at Sidney Kimmel Medical College at Thomas Jefferson University in Philadelphia, PA. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on Twitter @DrHovanesian. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an adviser for Zeiss, Bain Capital, Avellino Labs, CVC Capital, Anivive Lifesciences; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Lensgen, IanTech, Centricity Vision and Visus. Haller reports being on the board of directors at Bristol Myers Squibb, Opthea and Outlook Therapeutics. She is consultant to Aura Biosciences, Bionic Sight, Lowy Medical Research Institute and Regeneron.

For a very complex anterior segment reconstruction surgery, Brandon Ayres MD from Wills Eye Hospital is one of the best, performing many of these tough cases every week. This includes scleral fixated IOLs, prosthetic iris devices, corneal transplantation, pupilloplasty, and more. In this interview he gives a step-wise approach to these tough surgeries and a guideline for success, one step at a time. If you have a tough case coming up, you will benefit so much from this podcast! He also has a great youtube channel where he posts videos of these amazing surgeries. https://www.youtube.com/@brandonayres

We discuss the use of the PDS in the treatment of diabetic retinopathy and diabetic macular edema with Professor Carl Regillo of the Wills Eye Hospital.

Cristos Ifantides MD is an accomplished young ophthalmologist who truly brings the "A game" to the future of our field. He completed an international ophthalmology fellowship at the Wills Eye Hospital and he was previously a faculty member of the University of Colorado school of medicine, department of ophthalmology. He left that academic position and moved to Florida to join a private practice. Why? What changed? How is it different? Does he still get involved in clinical trials? How can you be a private practice ophthalmologist but also a notable teacher, key opinion leader, and young visionary? We go into all the details. So much to learn!

Laura Enyedi, MD, Susan MacDonald, MD, and Cathleen McCabe, MD, talk with Michelle Cabrera, MD, Lauren Hock, MD, Olivia Killner, MD, and Brittni Scruggs, MD, PhD, on the topic of sexual harassment in the field of ophthalmology. ·       Welcome to another episode of Mend the Gap :00 ·       The topic :06 ·       Introductions :18 ·       Trigger warning 3:38 ·       The scope and severity of sexual harassment 3:53 ·       Do you have advice for people in terms of when to report and how to address sexual harassment? 9:05 ·       Toolkit for Responding to Patient Initiated Verbal Sexual Harassment 17:38 ·       Workshop Curriculum for Responding to Patient Initiated Verbal Sexual Harassment 21:45 ·       Bystander interventions 26:36 ·       Reporting sexual harassment 30:41 ·       Sexual harassment in private practice 33:23 ·       Five-year follow-up study on sexual harassment in ophthalmology 37:21 ·       Thank you 38:49 We'd love to hear from you! Send your comments/questions to podcast@healio.com. Follow us on Twitter @Healio_OSN. References: Hock LE, et al. J Acad Ophthalmol. 2020;doi:10.1055/s-0040-1717062. Scruggs BA, et al. J Acad Ophthalmol. 2020;doi:10.1055/s-0040-1705092. Michelle “Mimi” Cabrera, MD, is an associate professor of ophthalmology at the University of Washington and head of ophthalmology at Seattle Children's Hospital. Laura B. Enyedi, MD, is professor of ophthalmology and pediatrics at Duke Eye Center and medical director of South Durham Ophthalmology in North Carolina. Lauren E. Hock, MD, is a board-certified ophthalmologist and fellowship-trained glaucoma specialist at the Wills Eye Hospital in Philadelphia, PA. Olivia Killeen, MD, is a pediatric ophthalmology and adult strabismus fellow at Duke University. Follow Dr. Killeen on X (Twitter) @olivia_killeen. Susan MacDonald, MD, is president of Eye Corps and associate clinical professor at Tufts School of Medicine. Cathleen McCabe, MD, is chief medical officer of Eye Health America and medical director of The Eye Associates in Sarasota, FL. Brittni Scruggs, MD, PhD, is a board-certified adult and pediatric vitreoretinal surgeon at Mayo Clinic. Disclosures: Cabrera receives grant funding from the Alcon Research Institute. Scruggs is a consultant for Genentech and Iveric Bio. Enyedi, Hock, Killeen, MacDonald and McCabe report no relevant financial disclosures.

Dr. Clark Chang is a cornea and keratoconus, KC, specialist at Wills Eye Hospital in Philadelphia and the Director of Global Medical Affairs at Glaukos. Keratoconus is a disease of the eye where tissue thins and gradually bulges outward into a cone-like shape.  While changes in the cornea are small, vision becomes very blurry, and the underlying cause may be overlooked. Glaukos has introduced the iLink procedure, a minimally invasive outpatient procedure to slow or halt the progression of this disease and help patients preserve their vision. Clark explains, "It is associated with age, but it's in the different group of people than most of your audience is thinking. We're very familiar with conditions like age-related macular degeneration. Everybody knows that because it's very impactful to one's vision, and the fear of loss of vision has frequently been rated as one of the top one or two biggest fears in a person's life. Most diseases are age-related in that they can occur with time. This disease more commonly occurs during puberty or in younger patients."    "In order to be able to diagnose this condition, especially at an early stage when there is an extremely small amount of change in the alteration in the shape of the cornea, you really need sophisticated diagnostic technology that we usually call topographer or tomographer. Basically, it maps out the shape of the cornea, either just at the front or front and back of your cornea. Being able to, in a more sensitive way, figure out whether or not there's any small amount of area that's becoming misshapen more than what a normal cornea or tissue would look like." #Glaukos #Keratoconus #iLink #CornealCrossinglinking #EyeHealth #KCAwareness #LivingwithKeratoconus #EyeDisease #Cornea  glaukos.com Download the transcript here

Dr. Clark Chang is a cornea and keratoconus, KC, specialist at Wills Eye Hospital in Philadelphia and the Director of Global Medical Affairs at Glaukos. Keratoconus is a disease of the eye where tissue thins and gradually bulges outward into a cone-like shape.  While changes in the cornea are small, vision becomes very blurry, and the underlying cause may be overlooked. Glaukos has introduced the iLink procedure, a minimally invasive outpatient procedure to slow or halt the progression of this disease and help patients preserve their vision. Clark explains, "It is associated with age, but it's in the different group of people than most of your audience is thinking. We're very familiar with conditions like age-related macular degeneration. Everybody knows that because it's very impactful to one's vision, and the fear of loss of vision has frequently been rated as one of the top one or two biggest fears in a person's life. Most diseases are age-related in that they can occur with time. This disease more commonly occurs during puberty or in younger patients."    "In order to be able to diagnose this condition, especially at an early stage when there is an extremely small amount of change in the alteration in the shape of the cornea, you really need sophisticated diagnostic technology that we usually call topographer or tomographer. Basically, it maps out the shape of the cornea, either just at the front or front and back of your cornea. Being able to, in a more sensitive way, figure out whether or not there's any small amount of area that's becoming misshapen more than what a normal cornea or tissue would look like." #Glaukos #Keratoconus #iLink #CornealCrossinglinking #EyeHealth #KCAwareness #LivingwithKeratoconus #EyeDisease #Cornea  glaukos.com Listen to the podcast here

On today's Ask Dr Jessica podcast, the guest is Dr Anya Sebring, pediatric ophthalmologist extraordinaire!   In this episode we discuss the most common questions that arise in children--we discuss the difference between an optometrist and an ophthalmologist,  normal vision development from infancy and beyond (4:52), how to protect our kids eyes (8:52),  kids & glasses & time outdoors (11:50), styes (17:54), conjunctivitis or red eyes (25:00-32:28), blocked tear ducts (32:30-38:25)  and more!Dr. Anya Trumler-Sebring was awarded her Doctorate of Medicine from the University of Nebraska Medical Center, where she subsequently completed an Internship in Internal Medicine and a Residency in Ophthalmology. She then completed a Fellowship in Pediatric Ophthalmology and Adult Strabismus at the University of California San Diego, followed by a second Fellowship in Pediatric Glaucoma and Anterior Segment at the Wills Eye Hospital in Philadelphia, PA.She spent 5 years practicing Pediatric Ophthalmology and Adult Strabismus as an Assistant Professor of Ophthalmology at the Johns Hopkins Wilmer Eye Institute in Baltimore, MD.Her specialty includes the diagnosis and treatment of pediatric and adult strabismus, pediatric cataracts, pediatric glaucoma and children with ocular disease. She also practices comprehensive pediatric and adolescent eye care.She is a Board Certified Ophthalmologist and is a member of the American Academy of Ophthalmology as well as the American Academy of Pediatric Ophthalmology and Strabismus. Dr. Trumler-Sebring has authored and co-authored numerous textbook chapters and research articles regarding pediatric cataracts, glaucoma and strabismus.To schedule a visit with her, please call 805-495-0458Or visit the website: for Miramar Eye SpecialistsGet matched with a therapist by using Better Help! Give it a try---invest in your mental health: https://betterhelp.com/askdrjessica for 10% off your first month of therapy. Thank you to Better Help for supporting the Ask Dr Jessica podcast.Dr Jessica Hochman is a board certified pediatrician, mom to three children, and she is very passionate about the health and well being of children. Most of her educational videos are targeted towards general pediatric topics and presented in an easy to understand manner. Do you have a future topic you'd like Dr Jessica Hochman to discuss? Email Dr Jessica Hochman askdrjessicamd@gmail.com. Dr Jessica Hochman is also on social media:Follow her on Instagram: @AskDrJessicaSubscribe to her YouTube channel! Ask Dr JessicaSubscribe to this podcast: Ask Dr JessicaSubscribe to her mailing list: www.askdrjessicamd.comThe information presented in Ask Dr Jessica is for general educational purposes only. She does not diagnose medical conditions or formulate treatment plans for specific individuals. If you have a concern about your child's health, be sure to call your child's health care provider.

Dr. Jason Hsu from Wills Eye Hospital returns to The Retina Channel to discuss his groups' retrospective study of eyes with advanced retinal detachement (PVR grade C or worse) that underwent retinectomy without lensectomy. Their study showed that 75% of these eyes at 3 months (and 68% at 6 months) had single surgery anatomic success. The study is suggestive that lensectomy and even peripheral vitreous base sheving may not be necessary when doing retinectomy for advanced RD cases.  Full reference to the article: Mahmoudzadeh R, Mokhashi N, Anderson H, Patel S, Salabati M, Chiang A, Kuriyan AE, Gupta OP, Mehta S, Garg SJ, Hsu J. Outcomes of Retinectomy without Lensectomy in Rhegmatogenous Retinal Detachments with Proliferative Vitreoretinopathy. Ophthalmol Retina. 2023 Jan;7(1):52-58. doi: 10.1016/j.oret.2022.07.008. Epub 2022 Aug 5. PMID: 35940476.

Join A Cure in Sight and Dr. Basil Williams to discuss Pros and Cons of Radiation to the Eye. Treatment options are covered, based on factors such as eye tumor location, size, possibility of retaining vision. Side effects of various radiation based treatments are discussed. The impact of a biopsy at time of treatment or before is discussed. Tune in and be sure to subscribe and share, plus make a contribution to keep our podcast going!  Basil K. Williams Jr. MD is an Associate Professor of Ophthalmology at the Bascom Palmer Eye Institute, where he specializes in ocular oncology and vitreoretinal diseases and surgery. He completed his ophthalmology residency and vitreoretinal surgery fellowship at Bascom Palmer and served as a chief resident and co-director of ocular trauma there as well. He then completed an additional fellowship in ocular oncology at Wills Eye Hospital. Dr. Williams grew up in the Bronx, NY and received his Bachelor of Arts Degree from Yale University before attending The Chicago Medical School. Prior to joining Bascom Palmer, he was the Director of Ocular Oncology at the University of Cincinnati and held the Mary Knight Asbury Endowed Chair of Ocular Oncology.    ANNOUNCEMENTS:   5K SITES ARE OPEN FOR REGISTRATION NEAR YOU! May 20, Raleigh, NC https://bit.ly/3KnyTwp   May 21, Washington DC https://bit.ly/3ZotGIZ   June 10, Minneapolis, MN https://bit.ly/3o5Mwr2   June 11, Philly, PA https://bit.ly/3U4hsUH   July 8, Seattle, WA https://bit.ly/3TTgvP3   July 15, Palo Alto, CA https://bit.ly/3lRFi9D   August 6, NYC/Brooklyn/Jersey area https://bit.ly/40KUtQH   Head to our site to register for a 5K Lookin' for a Cure near you for the remainder of the year!! www.lookinforacure.org   Stay tuned for registration announcements for the Eye Believe Survivorship Seminar happening in Seattle, WA, Sept 8-9, 2023! Subscribe to the newsletter to stay in the know Newsletter link   Email contact@acureinsight.org for questions regarding any upcoming events! ********* Be sure to follow us on Facebook, Twitter, Linked In, or  Instagram @acureinsight, for more stories, tips, research news, and ideas to help you navigate this journey with OM! *A Cure in Sight is a 501c3 organization. All donations made can help fund our podcast to educate patients, fund research, aid patients, and more! Donate $10 $15 $20 today to help A Cure in Sight in their quest to find a cure. Contribute via  PAYPAL OR VENMO or reach out directly to contact@acureinsight.org  The Eye Believe Podcast is brought to you by Castle Biosciences. Castle Biosciences is a leading diagnostics company improving health through innovative tests that guide patient care. The Company aims to transform disease management by keeping people first: patients, clinicians, employees and investors.  This podcast was hosted by Danet Peterson and produced by Page Fronczek.

Andrew Lam, M.D., is a dad, surgeon, and the award-winning author of three books, including his new release, The Masters of Medicine: Our Greatest Triumphs in the Race to Cure Humanity's Deadliest Diseases. His writing has appeared in numerous publications, including The New York Times and The Washington Post. He graduated summa cum laude in history from Yale University, where he studied military history and U.S.-East Asian relations. He then attended medical school at the University of Pennsylvania, followed by specialty training in ophthalmology and retina surgery at the Wills Eye Hospital in Philadelphia, where he also served as chief resident. LISTEN TO THIS EPISODE IF: You like hearing stories of historical heroes and mavericks who changed the world You want new insights into the past, present, and future of medicine You enjoy learning new things about how our history shaped the present You want to discover what we can learn from the mavericks who helped save countless lives through their example You want to learn about the crucial moments and people responsible for the world's greatest medical miracles You can learn more about Dr. Andrew Lam: www.AndrewLamMD.com. Facebook: @Andrew Lam Twitter: @Andrew_LamMD Instagram: @AndrewLamMD

We discuss the results of the RGX-314 study of subretinal gene therapy for neovascular AMD with Dr. Allen Ho, Professor of Ophthalmology, Wills Eye Hospital.

A Cure in Sight is joined by omie, Kathy Doocy, co-author of The Happy Cookbook, The Simply Happy Cookbook, and The Happy in a Hurry Cookbook.   Kathy Doocy was previously the host of ESPN's Sidelines and worked at NBC. WHen Kathy and Steve got married and the kids came along, Kathy retired from her TV work to raise the family and preside as the Doocy family CEO and CFO, and she's enjoyed every single minute of it.   Steve and Kathy have Three grown children who moved out and now miss their parent's delicious home-cooked meals every day. they live in New Jersey.   Regarding the Happy Cookbook:   "The year before we started this project, Kathy was diagnosed with ocular melanoma, an unbelievably rare and aggressive form of eye cancer. She was lucky that they caught it early and she was treated by Dr. Carol Shields and her team of specialists at the Wills Eye Hospital in Philadelphia. during her very first examination, Dr. Shields told Kathy, "I am going to save your life," and she did.   During her recovery, while taking stock of her life as many do when they've gone through something that life-changing, Kathy vowed to make it her personal quest to leave her children a written record of the foods they grew up loving. They don't cook much now, but they will someday.   This will always be a part of Kathy's legacy to Peter, Mary, and Sally, that whereever they travel in their lives, they'll always have a printed road map to their mom's signature suppers, provided they will actually cook and not order takeout on Uber Eats."   ANNOUNCEMENTS: Steps for Sight donations are still being gathered–share to help us fund research! www.charityfootprints.com/SFS Head to our site to register for a 5K Lookin' for a Cure near you! www.lookinforacure.org Subscribe to the newsletter to stay in the know Newsletter link   Email contact@acureinsight.org for questions regarding any upcoming events! ********* Be sure to follow us on Facebook, Twitter, Linked In, or  Instagram @acureinsight, for more stories, tips, research news, and ideas to help you navigate this journey with OM! *A Cure in Sight is a 501c3 organization. All donations made can help fund our podcast to educate patients, fund research, aid patients, and more! Donate $10 $15 $20 today to help A Cure in Sight in their quest to find a cure. Contribute via  PAYPAL OR VENMO or reach out directly to contact@acureinsight.org  The Eye Believe Podcast is brought to you by Castle Biosciences. Castle Biosciences is a leading diagnostics company improving health through innovative tests that guide patient care. The Company aims to transform disease management by keeping people first: patients, clinicians, employees and investors.  This podcast was hosted by Danet Peterson and produced by Page Fronczek.  

2 part session: Join the following three physicians as they discuss new advances in treatment of uveal melanoma of the eye. This session was sponsored in part by Aura Biosciences. They discuss the following:  -RADIATION RETINOPATHY -Pars plana vitrectomy (PPV) with diode -ENDORESECTION -ADVANCES IN TREATMENT OF THE EYE (Aura presentation) Dr. Scott Walter, a practicing ophthalmologist in Hartford, Connecticut and is affiliated with Hartford Hospital.  Dr. David Reichstein, an ocular oncologist, who studied at the renowned Wills Eye Hospital here from Tennessee Retina. Dr. Peter Hovland, who specializes in vitreoretinal disease & surgery, and ophthalmology, here from Colorado Retina.   At Aura, our mission is to develop a new class of oncology targeted therapies that deliver meaningful therapeutic benefit to a range of cancer indications with high unmet need in which we believe we can establish a new standard of care. We are driven by our passion and commitment to science and the patients battling cancer who are relying on us to pioneer these new therapies. Second half of episode: Understanding Genetics Testing with Castle Biosciences Join Dr. Reichstein, Dr. Hovland, and Dr. Walter for a discussion on genetics in uveal melanoma. This session is brought to you by Castle Biosciences. Castle Biosciences develops and commercializes diagnostic and prognostic tests for dermatologic cancers. These tests provide clinically actionable, tumor-specific genomic information to enable more accurate treatment plan decisions. They believe that the traditional approach to developing a treatment plan for dermatologic cancers using clinical and pathology factors alone is inadequate, and can be improved by incorporating personalized genomic information.  

In this session, Dr. Reichstein, Dr. Schefler, Dr. Hovland, and Dr. Walter will be discussing "Standards of Care for Uveal Melanoma, are there any?" Topics addressed include: - NCCN/TNM Staging & guidelines -Types of Plaque/Proton Beam Treatment -Transpupillary Thermotherapy (TTT) alone (and why we shouldn't do it)   Dr. David Reichstein, an ocular oncologist, who studied at the renowned Wills Eye Hospital here from Tennessee Retina. Dr. Amy Schefler, ocular oncologist and renowned eye cancer researcher from Houston Retina, joining us virtually. Dr. Peter Hovland, who specializes in vitreoretinal disease & surgery, and ophthalmology, here from Colorado Retina. Dr. Scott Walter, a practicing ophthalmologist in Hartford, Connecticut and is affiliated with Hartford Hospital.     

Join Dr. David Reichstein of Tennessee Retina to discuss what to expect in your eye after treatment. Dr. Reichstein is a graduate of the world's premier Ocular Oncology Fellowship at Wills Eye Hospital, under the direction of Drs. Jerry and Carol Shields. Dr. Reichstein's interests include the diagnosis and management of patients with all types of ophthalmic tumors, including uveal melanoma or nevus, retinoblastoma, vitreoretinal and choroidal lymphoma, vascular tumors of the posterior segment, and choroidal metastases. He also has expertise in the management of anterior segment tumors including conjunctival melanoma, conjunctival or corneal intraepithelial neoplasia, and squamous cell carcinomas of the anterior segment. Dr. Reichstein's therapeutic expertise includes the use of topical and systemic chemotherapy, surgical management of ophthalmic tumors, and radiation using brachytherapy or external beam radiation.

What do baseball Hall-of-Famers Frank Robinson and Willie Stargell, a library in Northeast Philadelphia, the towns of Radnor and Pottstown, Pennsylvania, a bed and breakfast in Tennessee, and the Wills Eye Hospital have in common?  The thread that connects these disparate entities is Bushrod Washington James, a Philadelphia physician and philanthropist who is interred at Laurel Hill West.  Find out why his name is quietly known across the country in this month's edition of Biographical Bytes from Bala: Laurel Hill West Stories.

In this episode, Nick and Scott are joined by Dr. David Reinchstein They first dive into David's relationship with sports and athletics before talking about how he found Nick and their built connection on eyes. They then discuss the work they do together on TAGALONG which has ultimately given David extra confidence in calling himself an Athlete. David Reichstein is an Ophthalmologist at Tennessee Retina. Dr. David A. Reichstein is a graduate of the world's premier Ocular Oncology Fellowship at Wills Eye Hospital. You can follow and join our community of Athletes on Instagram and Facebook. Don't forget to follow us on Instagram and Facebook for more training tips and updates. Follow Nick on Instagram & Facebook For more information about training with professional athletes, please visit www.tagalongwithapro.com Download the iOS app or Android app --- Support this podcast: https://anchor.fm/tagalongwithapro/support

Episode 31 features Dr. Oluwatosin Smith, MD, a renowned glaucoma specialist based at the Glaucoma Associates of Texas in Dallas. Dr. Smith is also an acclaimed global ophthalmologist who serves on the board of the 'Cure Glaucoma Foundation'. She is also an assistant professor of Ophthalmology at the University of Texas Southwestern. Dr. Smith obtained her MBBS from the University of Ibadan in Nigeria graduating with the Andrew Blair Aitken's Prize in Surgery. She completed her ophthalmology residency from Howard University graduating with the outstanding resident for the class of 2002 award. Thereafter, Dr. Smith obtained her glaucoma specialty training at the Wills Eye Hospital. In this segment, we discuss multiple aspects of global glaucoma work which includes research and service. We also go through Dr. Smith's path in ophthalmology and what the 'Cure Glaucoma Foundation' is!

Dr. George Magrath is CEO and a board-certified Ophthalmologist.  He has worked in the clinical research industry for 5 years.  George worked previously worked at Hovione, LLC Edison Investment Research Limited Medical University of South Carolina prior to joining Lexitas in August 2020.  He received a Bachelor of Science in biological chemistry from Clemson University and his medical degree from the Medical University of South Carolina.  He then stayed on at the Medical University of South Carolina to complete an internship in General Surgery and a residency in Ophthalmology.  Finally, he completed a fellowship in ocular oncology at Wills Eye Hospital in Philadelphia.  Upon completion of fellowship he returned to the Medical University where he served as the Chief of the University's Ocular Trauma Service.  He has 24 peer reviewed publications and has presented at multiple national and regional conferences.  In addition to his medical degree he holds an MBA from The Citadel and a Masters in Applied Economics from Johns Hopkins University.  He worked as an equity analyst at Edison Investments Research prior to transitioning to drug development as the Medical Director at Hovione.  At Hovione for the past 5 years, Dr. Magrath managed the clinical development of assets in dermatology, ophthalmology, and inhalation.  When he is not working, George enjoys hanging out with his wife and kids.Learn more at Lexitas

In this episode, Dr. Michael Cohen, an assistant professor at Thomas Jefferson University, Wills Eye Hospital, joins Louie Cai for a therapy session. They cover some of the new difficulties of being a new fellow including imposter syndrome, increased responsibilities, swallowing your ego, and how they almost went into psychiatry.

O doutor Vital tem uma carreira de muito sucesso na oftalmologia e hoje vai conversar conosco um pouco sobre sua história na oftalmo, fellow no exterior, carreira academia e falar sobre glaucoma, sua especialidade desde a época de Wills Eye Hospital em seu fellow norte-americano. Não deixe de ouvir!

Episode 9: Introduction to Ocular Oncology Description: In this episode, we speak with Dr. Carol Shields to get a broad overview of ocular oncology. Dr. Shields is Chief of the Ocular Oncology Service at Wills Eye Hospital and Professor of Ophthalmology at Thomas Jefferson University in Philadelphia. She completed her ophthalmology training at Wills Eye and subsequently did fellowship training in ocular oncology, oculoplastic surgery, and ophthalmic pathology. Episode Goals: After listening to this episode, medical students should be able to: ● Acquire a general understanding of the breadth of practice for ocular oncology ● Describe the common examination and imaging techniques in ocular oncology ● Describe common pathologies seen and procedures/surgeries performed in ocular oncology Time Stamps: Introductions - 0:30 What is ocular oncology? - 2:20 How did you discover ocular oncology? - 3:30 How can students explore ocular oncology? - 5:00 How do you become an ocular oncologist? - 6:40 Overview of eyelid tumors - 9:05 Overview of conjunctival tumors - 15:05 Overview of conjunctival tumors - 15:05 Overview of orbital tumors - 23:25 Overview of intraocular tumors - 31:06 Additional resources - 42:50 Conclusions - 44:20 Links: https://www.willseye.org/

Dr. Duker is an accomplished ophthalmologist, that is now the Chief Operating Officer of EyePoint Pharma, a biotech company that develops sustained-release medications to treat serious ocular disorders. We talked about his career path and what motivated him to move from a clinical to an executive position. For the 21 years before he took the COO position at EyePoint, Dr. Duker was the Director of the New England Eye Center (NEEC) and Professor and Chair of the Department of Ophthalmology at Tufts Medical Center, Tufts University School of Medicine in Boston, Massachusetts. Dr. Duker received his medical degree from Jefferson Medical College. He completed a residency and fellowship in vitreoretinal diseases and ocular oncology at the Wills Eye Hospital.

We review current status of clinical research on gene therapy for neovascular AMD and diabetic retinopathy with Dr. Allen Ho, Professor of Ophthalmology, Jefferson Medical College and Wills Eye Hospital.

We review the results of the KS-301 wet macular degeneration trial with Dr. Carl Regillo,Chief of the Retina Service at Wills Eye Hospital

In this episode, we are joined by Dr. Brenton Finklea who is the co-director with Dr. John Anhalt of the Wills Eye Center for Academic Global Ophthalmology. He obtained his medical education from the University of Virginia and then subsequently conducted ophthalmology residency training at the Wills Eye Hospital. Post-residency, he obtained fellowship training in 2 areas. One in Cornea, External Diseases, and refractive surgery from Duke University and the other in Academic Global Ophthalmology from the Wills Eye Hospital. As a trainee he has received multiple awards for his outstanding performance, ranging from intern of the year and the James Shipman Award for best resident paper presentation. We are very fortunate to have a guest like him join us today.

We discuss the use of the newly approved Susvimo system for sustained delivery of ranibizumab in the treatment of neovascular AMD with Carl Regillo, MD, Professor of Ophthalmology Thomas Jefferson University and Director of the Retina Service at the Wills Eye Hospital.

**Dr. Constance Okeke received her undergraduate and medical degrees from Yale and trained in ophthalmology at the Wilmer Eye Institute of Johns Hopkins. She completed her glaucoma fellowship training as a Heed Research Fellow at the prestigious Bascom Palmer Eye Institute of University of Miami. She became a clinician scientist under a National Institute of Health K12 grant at the Scheie Eye Institute of University of Pennsylvania, where she also earned a Master of Science degree in clinical epidemiology. She has practiced ophthalmology with a specialty in glaucoma and cataract surgery since 2001. Dr. Okeke single-handedly pioneered micro-invasive glaucoma surgery (MIGS) at Virginia Eye Consultants in the southern Virginia Hampton Roads region. In 2009, she was the first in the area to perform Trabectome surgery and was the first in the country to combine this advanced technology in glaucoma with the femtosecond laser, allowing the surgery to be performed without a blade. **Opthamologist Dr. Leslie Jones-Dr. Jones is an associate professor in the College of Medicine and serves as the residency program director and director of Glaucoma Services in the department. Dr. Jones completed her medical degree in 1996 and ophthalmology residency in 2000 at Howard University and Howard University Hospital, followed by a fellowship in glaucoma at Wills Eye Hospital, the country's oldest eye hospital located in Philadelphia, Pennsylvania.    Dr. Jones is the recipient of the American Glaucoma Society Clinician Scientist Award 2005. Her research focuses on the genetic epidemiology of glaucoma, the evaluation of current and innovative glaucoma medical and surgical therapies, and use of on-line simulation as an adjunct to traditional ophthalmic clinical skills training.

Episode 7: Introduction to Neuroophthalmology Description: In this episode, we speak with Dr. Kalla Gervasio to learn about what medical students should know before their first neuro-ophthalmology clinic and OR. Dr. Gervasio completed her ophthalmology residency at Wills Eye Hospital where she was selected as Chief Resident and Text Editor of the newest edition of the Wills Eye Manual. Episode Goals: After listening to this episode, medical students should be able to: Acquire a general understanding of the breadth of practice for the neuro-ophthalmology subspecialty. Describe the common examination and imaging techniques in the neuro-ophthalmology clinic Describe common pathologies seen and procedures/surgeries performed on the neuro-ophthalmology service. Time Stamps: Introductions - 0:30 What is Neuroophthalmology - 4:00 Tips for medical students - 7:30 Overview of anatomy - 9:15 Common examination techniques - 15:00 Minor procedures - 21:00 Blepherospasm - 21:30 Common pathologies to review before starting - 23:30 Origins of interest in neuroophthalmology - 30:00 Common questions on rotations - 33:00 Links: Tim Root OphthoBook: https://timroot.com/ Slit lamp techniques: https://www.slideshare.net/optometristiem.lv/slit-lamp-illumination-techniques

The Director of Retina Services at Wills Eye Hospital joins to discuss the historic FDA approval granted for a novel method of ophthalmic care: a permanent implant that allows for vision-saving formula therapy to treat the eye continually. Read more about the PDS approval here. Episode notes: 0:12 Intro 1:07 What is the Port Delivery System? 2:39 The history of developing the PDS 17:00 Is PDS exclusive to anti-VEGF? 19:52 Thoughts on the ranbizumab PDS approval 23:10 How will guidelines change? 24:15 Tips for best PDS use 26:30 Closing thoughts 29:40 Outro

Episode #6 is being produced in honour of World Keratoconus Day, celebrated around the world on November 10th. This episode is jam-packed with crucial insight from company Avellino - a leader in precision medicine, is making a global impact in genetics and bringing innovative diagnostics, therapies, and AI-driven data processing to patient care. A special thank you goes out to our 2 guests this week: Joe Boyd: Mr. Boyd is the Global Head of Sales and Marketing for Avellino, a global leader in gene therapy and molecular diagnostics at the forefront of precision medicine for eye care. He has more than 20 years of experience in life sciences and medical devices and is a sought-after speaker in the science and medical industry. Brandon Ayres, MD: Brandon Ayres, MD is a board certified ophthalmologist at Wills Eye Hospital who specializes in all forms of corneal transplantation and all types of refractive and cataract surgery, including LASIK. Dr. Ayres also treats infectious diseases of the eye and ocular surface disease (dry eye). He has an interest in the diagnosis and treatment of keratoconus and has been involved in several FDA trials investigating new treatments for the condition. Avellino has launched its first genetic test, AvaGen™. AvaGen™ is an eye test that confidently empowers eyecare professionals to protect and preserve vision by providing personalized genetic data that accurately quantifies the risk or presence of sight-threatening conditions.

A Cure in Sight is joined by Mila and her mom, Kezia, as well as Presley and his mom Stephanie to speak to their journey with ocular melanoma. Here's a short snippet of each of their stories--tune into the podcast to listen fully! Be sure to subscribe, and share this episode with your friends and family on social--and we would LOVE it if you would consider making a donation to ACIS, or creating a fundraiser on social media to help us raise money for a cure. Meet Mila, a 14 year old who was diagnosed with Ocular Melanoma in Jan 2021, after experiencing vision loss and changes from August to November 2020. After months of being referred to one specialist after another and not having solid answers, they were sent to a retina specialist, who then sent them to Boston 5 days later to begin the process of treatment for Ocular melanoma through Proton beam therapy. And meet Presley, a now 15 year old who was diagnosed with Ocular Melanoma at the age of 13 on Dec 17, 2018. “Doctor's found a large tumor in his right eye that had already destroyed his eye sight in that eye permanently. Immediately after diagnosis, it was determined that Presley needed to undergo plaque radiation therapy of his eye.” He shares in the podcast how this procedure was extremely painful for him and a long few days in the hospital. “Presley underwent 3 separate surgeries in 10 days and underwent 5 continuous days of plaque radiation therapy in Philadelphia, he was treated at Wills Eye Hospital by Dr Jerry & Dr Carol Shields.” He and Stephanie speak to this experience and how taxing it was on their family to receive this news, and also to travel for treatment. Both teens expressed how this has been a challenge, but as you'll hear throughout this episode, they rise to the challenge beautifully and truly are the definition of resilience. A special tribute for pediatric cancer awareness, especially those in our pediatric community fighting metastatic disease or who we have lost to this cancer. You are not forgotten.

We discuss the use of a cooling probe as primary anesthesia for intravitreal injection with Ajay Kuriyan, MD, Associate Professor of Ophthalmology, Wills Eye Hospital.

In this episode of Seeing Clearly, Emaan Chaudry and Danielle Solish talk to Dr. Caroline Baumal, a Professor of Ophthalmology at New England Eye Center, Tufts Medical Center in Boston, MA. Dr. Baumal specializes in diseases and surgery of the retina and vitreous. Her research interests include novel retinal imaging and drug development, which continue from her early career research using the first prototype OCT and working with drug implants and photodynamic therapy. Her clinical interests include age-related maculopathy, diabetic retinopathy, complex vitreoretinal surgery, and retinopathy of prematurity (ROP). Dr. Baumal completed medical school and ophthalmology residency at the University of Toronto after undergraduate studies at McGill University. She completed two fellowships: one at New England Eye Center, Boston in Medical Retina and Lasers and another in Vitreoretinal Diseases and Surgery at Wills Eye Hospital in Philadelphia. Dr. Baumal is Board Certified by the American Board of Ophthalmology She received the Crystal Apple and Senior Honor Awards from the American Society of Retinal Specialists, the Senior Achievement Award from the American Academy of Ophthalmology and the Donald Gass Beacon of Sight award from the Florida Ophthalmologic Society. She has been appointed to the ASRS Retina Hall of Fame and was listed as a the Top 100 Female Ophthalmology in 2021. She is on the editorial board for Ophthalmic Surgery, Lasers and Imaging (OSLI) Retina and Retina Cases and Brief Reports journals. Dr. Baumal has authored over 150 publications, 28 book chapters on retinal diseases and recently edited the book Treatment of Diabetic Retinopathy. She is actively involved in teaching vitreoretinal fellows and residents and was previously Director of Education and the Residency program at New England Eye Center` In this episode, we discuss: - What drew Dr. Baumal to the field of ophthalmology. - What a day in the life of a retina specialist looks like. - Completing medical school in Canada and then transitioning to practice in the United States. - What it's like to be a practicing physician who is also involved with research and clinical trials. Check out our website: www.eyecurriculum.com Follow us on Instagram: www.instagram.com/EyeCurriculum Follow us on Twitter: www.twitter.com/EyeCurriculum

I was diagnosed with Choroidal Melanoma in March of 2008.   My optometrist found a freckle in my eye at a routine exam. I wasn't going to say anything, but I eventually told her that I had been seeing a flash of light in my right eye for several months.   She sat me back down in the chair and took a much longer, more careful look. She said that she wasn't qualified to diagnose anything, but that I had better have someone else take a look. She sent me to a retina specialist the next day. She actually called and made the appointment right there.   The retina specialist said the freckle was small, but that I should go to Wills Eye Hospital in Philadelphia to have them take some pictures and monitor it. Luckily Philadelphia was only an hour away from my house. His office actually called and made the appointment while I was standing there waiting to go home to tell my husband. I went the following Monday morning.   Dr. Shields came in the room and said, “We think you're going to be alright.” But she thought I had melanoma. I had no idea you could get that in your eye. She asked me what I was doing that following Thursday.   I scheduled plaque radiation. My husband brought me, and stayed in a hotel nearby for the five days the plaque was on my eye. This was right before Holy Week, the busiest time for a church musician. I remember having to sing by candlelight, not being able to see out of one eye, and spending much of the week doing music in church.   Later that year, the biopsy came back monosomy 3, the most dangerous mutation. To this day, every time I go to Wills, Dr. Shields remarks that she can't believe a tumor as small as mine was monosomy, and how lucky I am that we found it that small.   Early on, when I was having scans once a year and going to Wills every year, I started seeing Dr. Takami Sato to monitor for metastasis. I am currently NED 13 years later. Since my diagnosis, I have become a certified yoga teacher, a Licensed Massage Therapist, I have retired from my career as a full-time church musician, and have become a self-employed freelance musician, substitute organist/director, massage therapist, and yoga teacher.

“Life only gives you what you can handle, well apparently life thinks I'm a badass” Hi, my name is Nicolette Pagliei and I am 22 years old from West Chester PA. At 22 years old I just graduated from Kutztown University in May where life was just perfect, and I was so ready to take that next step into the world, but the world had different plans for me. And even though the world was already different because of this crazy pandemic and my life changed completely on September 28th, 2020, when I was diagnosed with Ocular melanoma. After seeing many eye doctors, I was treated at Wills Eye Hospital, where I did plaque radiation and lost most of my vision in my left eye. This experience has taught so much about myself as I was told I had cancer alone while family could only facetime in because of restrictions, this taught me strength and perseverance, and so much more. This experience has been hard, when physically I feel amazing and mentally, I must deal with vision loss, and the nerves when I have to drive in the rain or at night, and the look on people's faces when I say that only can see out of one eye, it truly is a mind game, but I can say I am playing and forever will. I would be lying if I said I did not worry every single day. Worry about cancer coming back, worry about something happening to my good eye, worry, worry, worry but I have to say what gotten me through is the people I surround my self with. My mom, dad, and sister Brianna are my rocks and lift me up every day, my boyfriend Nik keeps me going daily, my friends, family, doctors and nurses who take care of me and everyone in between are the reason I keep playing this game. And although at 22 I thought life might be a little different, but I wake up every day and keep going, because I do have so much to see in this world. And Ocular melanoma would never take over my life but gives me more of reason to keep living. Eye Believe!

Our first guest speaker to start off the conversation on Global Ophthalmology is Dr. Zubair Ansari. He is the Assistant Professor of Clinical Ophthalmology at Bascom Palmer Eye Institute and currently practices comprehensive Ophthalmology where he specializes in cataracts and refractive disease. He has a wealth of information regarding Academic Global Ophthalmology, which he conducted fellowship training in at the Wills Eye Hospital. This session is nothing short of gold for listeners as he explains what the field is about, unique lessons learned abroad, and what it means to harness the lessons abroad to use them in our own country to create equity. Disclaimer: As a student-led initiative, open.globe.talk is a platform to share information regarding global ophthalmology. While we encourage all our viewers to use the resources we have assembled here, we would like to mention that not all information may be found on our website and we continue to edit resources for your educational purposes. If you are considering applying to a training program, please contact the respective department of the program you are interested in so that you can obtain direct and updated information. We wish you the best in your academic endeavors and are honored to have you as part of our growing digital family! Disclaimer: No guarantee is given regarding the accuracy of any statements or opinions made on the podcast or website by the organization's leadership or guest speakers. In no way does listening, reading, emailing or interacting on social media with our content establish a doctor-patient relationship. You agree not to use this podcast or blog as medical advice to treat any medical condition in either yourself or others, including but not limited to patients that you are treating. Under no circumstances will Rizul Naithani, other organization leadership personnel, or any guest speaker be responsible for damages arising from use of the podcast or blog. Rizul Naithani does not receive any money from any pharmaceutical or device company. Additionally, this blog and podcast should not be used in any legal capacity whatsoever, including but not limited to establishing “standard of care” in a legal sense or as a basis for expert witness testimony.

Vision care must be a core part of the concept that “health is wealth.” Dr. Mark Ruchman, Chief Medical Officer at Versant Health, a managed vision care and benefits company, discusses the social and financial impact of eye disease; everyday steps people can take to protect their eye health; the most common eye diseases and their financial costs; and how telemedicine is being integrated into treatment plans. Mark Ruchman, M.D. is a board certified, fellowship-trained ophthalmologist and ophthalmic plastic surgeon in Waterbury, CT. He has over forty years' experience as a practicing ophthalmologist and over thirty years' experience in managed eye care including policy development, technology assessment, quality improvement and utilization management. Since 2018, Dr. Ruchman has served as the Chief Medical Officer of Versant Health, a managed vision care and benefits company. His work has appeared in several peer-reviewed manuscripts since 1974 and he also regularly contributes thought leadership pieces in health and benefits trade outlets (e.g. ThinkAdvisor, BenefitsPro, Ophthalmology Times, etc.). He is the current Director of the International Eye Foundation, the nation's oldest charitable foundation devoted to reducing blindness and promoting healthy vision, and is a member of the American Society of Ophthalmic Plastic Reconstructive Surgeons and a Fellow of the American Academy of Ophthalmology. Dr. Ruchman is a graduate of Yale University's Medical College and completed his residency in Ophthalmology and a fellowship in Ophthalmic Plastic & Reconstructive Surgery at Wills Eye Hospital in Philadelphia. He also was a Phi Beta Kappa graduate of Williams College, graduating Magna Cum Laude. #VersantHealth #Telemedicine

Dr Carol Shields, world leading ocular oncologist joins me for a chat about her incredible career, being at the top of ophthalmology power lists, life at Wills Eye Hospital and being admitted to a basketball hall of fame. Carol is an amazing surgeon and academic who has dominated her specialty yet remains incredibly humble. I'm sure you'll enjoy this insight into her life and gain some practical tips along the way.

On March 21, 2021, our host Dr. Marianne Ritchie was joined by Dr. Robert Lehman, Jr., a board-certified ophthalmologist and member of the Cataract and Primary Eye Care Service at Wills Eye Hospital, and Dr. Leo J. Maguire, an Associate Professor of Ophthalmology at the Mayo Clinic! These world-class ophthalmologists are at the top of their field with vast experience in the treatment of common and rare diseases of the eye. Learn how to protect your precious gift of vision.​Your Real Champion: Please, Mr. Postman​Each week we highlight the #RealChampions in your life! Your family, friends, or colleagues who go the extra mile to help others in their community. For this week, Your Real Champion was Bette Ross!For years Bette was a volunteer in nursing homes and retirement centers. Many of the residents never have visitors during the year, but it's especially sad for them at holiday time. Listen to the story of the Caring Kids Christmas Card Program and how it brings joy to thousands of lonely hearts​

Retinoblastoma is a rare form of eye cancer that affects infants and young children. In recent years, significant advances have been made in retinoblastoma diagnosis and treatment, helping not only save children's lives but in many cases preserving vision in the eye affected by cancer. On this episode of ASRS's Retina Health for Life, Dr. Carol Shields of the Wills Eye Hospital  joins Dr. Timothy Murray to discuss the causes of the condition, symptoms parents should be aware of and the importance of early, personalized treatment to ensure the best outcomes for children and their families.Resources: Access a downloadable fact sheet on retinoblastoma here. 

Dr. Javitt has played leadership roles in seven successful healthcare IT and biopharma startups with public exits. He has additionally led drug-development engagements for Merck, Allergan, Pharmacia, Novartis, and Pfizer. He was appointed to healthcare leadership roles under Presidents Reagan, George H.W. Bush, Clinton, and George W. Bush. In the latter role he was commissioned to lead the White House policy for universal adoption of Health IT and establishment of the Office of the National Coordinator. He is a graduate of Princeton University, Cornell University Medical College, Harvard School of Public Health, the Wills Eye Hospital, and Johns Hopkins Medical School. Dr. Javitt has published more than 200 scientific works in the areas of health outcomes and pharmacoeconomics that have been cited by more than 16,000 people.

In this episode, I chat with Dr. Kalla Gervasio, who resides as one of the Chief Residents at Wills Eye Hospital.    Dr. Gervasio shares her journey into ophthalmology and what led her to pursue two fellowships in neuro-ophthalmology and oculoplastic surgery upon completion of her residency training this year. Dr. Gervasio describes these two subspecialties and what makes them unique for any medical student interested in ophthalmology who may not have heard of them. We discuss how she is the co-founder of the Journal of Narrative Vision, her previous background studying the classical humanities, and how all this experience ties into navigating daily with her role as Chief Resident. Finally, we discuss some tennis so stick around for that if you are a fan of the game!   You can follow Dr. Gervasio on Twitter @Kalla_Gervasio and Instagram @dr.kallagervasio. Be sure also to follow Wills Eye Hospital on Twitter @Wills_Eye and the residents on Instagram @willseyeresidents.

In this episode, I chat with Dr. Michael Klufas. Dr. Klufas is an Assistant Professor of Ophthalmology at Thomas Jefferson University and a Vitreoretinal Surgeon on the Retina Service at Wills Eye Hospital with Mid Atlantic Retina.   Dr. Klufas discusses his journey into ophthalmology and his reflections on his career path. As a vitreoretinal surgeon and reviewer of surgical videos for Eyetube, Dr. Klufas walks through a recent case, representing some of the technology and techniques commonly used in his specialty. With his recent induction this year into the Retina Society, Dr. Klufas shares his experience with key mentors who have guided him and how hard work and collaboration combined led him to be at this point in his career.    You can follow Dr. Klufas on Twitter @NJRetinaDoc and the Wills Eye Hospital @Wills_Eye. Be sure to visit Dr. Klufas' website at www. drklufas.com

In this episode, I chat with Yoshihiro Yonekawa, MD. Dr. Yonekawa is a pediatric and adult retinal surgeon at Wills Eye Hospital and Mid Atlantic Retina and resides as an Assistant Professor of Ophthalmology at Sidney Kimmel Medical College at Thomas Jefferson University. We discuss his early fascination with microsurgery and how the mentorship of Dr. Paul Chan, a former guest of the show and current Chair of the Department of Ophthalmology at the Illinois Eye and Ear Infirmary, was instrumental in introducing him to pediatric retina. Dr. Yonekawa shares what makes the field of pediatric retina so unique within the specialty of vitreoretinal surgery and how worldwide the call to action is being taken by many retina specialists to address the burden of retinopathy of prematurity. With a passion for clinical research, Dr. Yonekawa and I discuss how he sees the philosophy of collaboration in research as key to driving the field forward in exciting directions. His successful career expands outside clinical care and research initiatives. Dr. Yonekawa is on the Executive Committee for the Vit Buckle Society (VBS) and is also the Vice President for Academic Programing amongst his many other societal memberships and editorial positions for high-impact journals in ophthalmology. He shares the importance of being a part of the community of fellow retina specialists and the spirit of camaraderie at the heart of VBS. With a career that has been decorated in awards from his early days of training at Harvard medical school's Mass. Eye and Ear Infirmary and his vitreoretinal surgery fellowship at the Associated Retinal Consultants/William Beaumont Hospital, Dr. Yonekawa reflects on this recent honor he had of being inducted into the Retina Society. Finally, we touch on the advice Dr. Yonekawa has for prospective ophthalmology applicants and what he views as crucial pieces to a successful match. Dr. Yonekawa believes the drive, sense of mission, and passion for bettering the lives of patients and colleagues is the foundation of a career rooted in purpose. You can follow him on Twitter @YoshiYonekawaMD.

The disruptions to clinical and surgical workflows during the COVID-19 crisis are obvious. Less apparent are the downstream effects of adjustments to educational experiences. New Retina Radio host John Kitchens, MD, invites three leaders in academic retina—Sophie Bakri, MD, of the Mayo Clinic; Julia Haller, MD, of Wills Eye Hospital; and R.V. Paul Chan, MD, MSc, MBA, of the University of Illinois at Chicago—to discuss how training and selection of fellows has been altered during the COVID-19 pandemic, and to review the tactics their institutions have employed to mitigate the interference their programs have endured.

The disruptions to clinical and surgical workflows during the COVID-19 crisis are obvious. Less apparent are the downstream effects of adjustments to educational experiences. New Retina Radio host John Kitchens, MD, invites three leaders in academic retina-Sophie Bakri, MD, of the Mayo Clinic; Julia Haller, MD, of Wills Eye Hospital; and R.V. Paul Chan, MD, MSc, MBA, of the University of Illinois at Chicago-to discuss how training and selection of fellows has been altered during the COVID-19 pandemic, and to review the tactics their institutions have employed to mitigate the interference their programs have endured.

Wall Street to Main Street hosts continue to explore the impact that the COVID-19 pandemic is having on various sectors of the economy. In this episode, guest Dr. Ravi Goel joins the conversation to explore the healthcare industry and take a dive into what is going on for medical practitioners who are not on the so-called "frontlines." Ravi Goel, MD, is an ophthalmologist with Regional Eye Associates in Cherry Hill, NJ and a clinical instructor at the Wills Eye Hospital, and writes a personal blog entitled ProtectingSight.com.

Dr. Julia Haller, ophthalmologist-in-chief at Wills Eye Hospital, joins the program to discuss her career development, her connection to Tom Clancy, future goals for Wills Eye Hospital, and more. Dr. Sridhar is a consultant for Alcon, Alimera, Regeneron, and Oxurion. Dr. Haller has no disclosures relevant to the subject matter of this podcast.

Dr. Vander from Wills Eye Hospital discusses the effect of vitreous tap on the management of 60 cases of endophthalmitis post intravitreal anti-VEGF injections. The discussed article:  Changes in Management Based on Vitreous Culture in Endophthalmitis After Intravitreal Anti-vascular Endothelial Growth Factor Injection. Patel SN, Storey PP, Pancholy M, Obeid A, Wibbelsman TD, Levin H, Hsu J, Garg SJ, Dunn JP, Vander JF. Am J Ophthalmol. 2019 Nov;207:224-231. doi: 10.1016/j.ajo.2019.06.008. Epub 2019 Jun 13

Dr. Allen Ho of Wills Eye Hospital rejoins the program to discuss updates in pharmacotherapy for macular degeneration, including gene therapy applications.Financial Disclosures: Dr. Sridhar has received consulting fees from Alcon, Alimera Science, and Oxurion. Dr. Ho's relevant financial disclosures include consulting fees for Iveric, Johnson & Johnson, and RegenexBio.You can now claim CME credits via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audio&sub=ONE.ContentTypes.Audio.

Burnout is an epidemic that is killing doctors and patients alike. Did you know that the number one cause of death for female physicians under 35 is suicide. Yes, Physicians have the highest rates of suicide of any career and female physicians are 250% more likely to commit suicide than any other occupation. Our featured guest today is Dr. Thandeka Myeni. Thandeka Myeni, MD, MPH, affectionately known as Dr Thandi, is a board-certified ophthalmologist with double specialty training in glaucoma, cataract surgery and LASIK.    Dr. Myeni received her bachelor’s degree from Amherst College and later earned a master’s degree in Public Health from Harvard University. She obtained her medical degree from the Medical College of Georgia and then completed her medical internship at Boston University Medical Center.    Her ophthalmology training began with a residency at Howard University Hospital in Washington, DC. She has completed two fellowships, one in Glaucoma at the top-ranked Wills Eye Hospital in Philadelphia, and another in Cataract and Refractive Surgery with Dr. Paul Koch who has consistently been ranked among the top cataract surgeons in the country.    While Dr. Myeni was born and raised in the United States, her family is originally from Southern Africa. She spent a large part of her childhood in Swaziland.  My ask today is that you’d help share this episode. If you're posting to social, please tag @tbpod and use the hashtag #missionfuel  

Dr. Sarah Driscoll Kuchar '01 is an ophthalmologist with Princeton Eye Group. After graduating from Stuart, Dr. Kuchar attended Yale University, received her medical degree from Rutgers-Robert Wood Johnson Medical School, and completed her ophthalmology residency training at the renowned Wills Eye Hospital in Philadelphia.   Sarah is a highly awarded athlete. At Stuart she played field hockey, ice hockey and lacrosse and at Yale she earned varsity letters all four years in both field hockey and lacrosse. She was Yale's all-time leading point scorer in field hockey and 2005 Female Athlete of the Year.    Sarah is also an accomplished marathon runner and mother to two young children.

Ms. Fran Fulton, the first patient to receive the ARGUS at Wills Eye Hospital in Philadelphia, PA, and Dr. Allen Ho of the Wills Eye Hospital join the program to discuss what the ARGUS is and the potential impact it can have on a patient’s quality of life. [0:57] Introduction [1:30] Fran discusses her ocular history prior to meeting Dr. Ho. [3:51] Dr. Ho discusses the ARGUS device, how it is implanted, and how it works. [5:40] Fran discusses her experience as a patient receiving the ARGUS device. [8:00] Fran talks about how the ARGUS device has affected her life. [9:26] Dr. Ho’s thoughts on possible future improvements for the device. [12:20] Fran discusses how Retinitis Pigmentosa has affected and will affect her family. [14:40] Dr. Ho’s closing remarks on how advancements in vision can come about. [15:42] Conclusion

Please join us Wednesday, June 14, 2017 at 4:00 p.m. PST and 7:00 p.m. EST for a live show with host Denise Messenger. Her special guest is Dr. Eric Donnenfeld. He will be discussing a new dry eye treatment. Eric Donnenfeld, MD, is a founding partner of Ophthalmic Consultants of Long Island and Connecticut.  He graduated magna cum laude from Dartmouth College in 1977 and first in his class at Dartmouth Medical School in 1980.  He was a resident and Chief Resident at Manhattan Eye, Ear and Throat Hospital and he completed a Cornea Fellowship at Wills Eye Hospital in 1985.  He is a trustee of Dartmouth Medical School and a clinical professor of ophthalmology at NYU. He has served as Resident Instructor at Manhattan Eye, Ear and Throat Hospital and as Program Director at North Shore University Hospital.  He is a National Medical Director of TLC and Surgical Director of the Lions Eye Bank for Long Island.  Dr. Donnenfeld served as president of many professional societies including the Nassau Surgical Society, cornea section of ASCRS, the Ophthalmology Division of the Nassau Academy of Medicine, and the International Ocular Microbiology and Immunology Group.  He is the past president of ASCRS and is in the presidential succession line for the International Intraocular Implant Society. Dr. Donnenfeld is the editor-in-chief of EyeWorld and the editor in chief emeritus of Cataract and Refractive Surgery Today. He has written over 190 peer review papers on cornea, external disease, cataract and refractive surgery, and 30 book chapters and books.  He is on the editorial board of 9 journals and has participated in over 60 FDA studies.  He is a Fellow of the American Academy of Ophthalmology and has received its Honor Award, Senior Honor Award, Life Time Achievement Award, and Secretariat Award. You asked for it and we deliver.

Dr. Julia Haller, ophthalmologist-in-chief at Wills Eye Hospital in Philadelphia, PA, joins the podcast to discuss the recent legal case of Dr. Salomon Melgen, a vitreoretinal specialist in Florida found guilty in April 2017 of over 60 counts of Medicare fraud.

Dr. William Tasman, former ophthalmologist-in-chief at Wills Eye Hospital in Philadelphia, PA, passed away March 28th 2017. Several of his colleagues join the show to share their thoughts on Dr. Tasman's legacy and influence.

Dr. Sunir Garg of Wills Eye Hospital and Mid Atlantic Retina in Philadelphia, PA joins the show to discuss switching from academics to an academic private practice, getting involved in clinical trials as a young attending, and why he prefers perfluorocarbon for retinal detachment repair.

Dr. Sonia Mehta of Wills Eye Hospital in Philadelphia, Pennsylvania joins the podcast to discuss how she approaches uveitis diagnosis and management, working in an academic private practice setting, and having a twin in ophthalmology.

Dr. Jason Hsu of Wills Eye Hospital in Philadelphia, PA joins the podcast to recap the highlights from the 2016 Winter Wills Retina Update conference and talk about the impact of the late Dr. J. Arch McNamara. Also, Jay describes a surgical case employing the 'no touch' technique for removal of an anteriorly migrated dexamethasone implant.

Dr. Carl Regillo of the Wills Eye Hospital in Philadelphia, PA joins the podcast to discuss treat and extend strategies for wet age-related macular degeneration (AMD), his approach to retinal detachment surgery, and other topics. Also, Dr. Yewlin Chee of the University of Washington joins the podcast in this week's Young VR Surgeon Spotlight.

Charlie Sheen and body images in Hollywood because of the Oscars Dr. Veronica Anderson is a dynamic advocate for living with optimum health and wellness every day. During her career, she has counseled thousands of patients to incorporate healthier food plans or eating styles (Dr. Veronica hates the word diet) and motion (not exercise) into their lives. These are but a few of the ingredients she adds to her recipe for full, happy lives. Also modeling what she teaches Dr Veronica has run two marathons for charity, and has a black belt in tae-kwon-do. She is the host of Wellness for the Real World on WebTalkRadio.net, a weekly talk show dedicated to wellness in mind, body and spirit, and also serves as host for Medicine Woman, Modern World, a healthy living travel adventure series for the web. As an entertaining, lively and provocative guest, she has appeared on national TV talk shows such as Our World with Neil Cavuto (Fox News Channel), and Lives with Adam Carolla (syndicated). In addition, radio hosts coast to coast have seen their lines light up as listeners clamour to hear more of Dr. Veronica's straightforward, pull-no-punches philosophy. Determined to become a doctor at age four, she completed pre-med at Princeton University, received her MD with honors after internship and residency at Robert Wood Johnson University Hospital and New York's Mt. Sinai Medical Center, where she received a fellowship in glaucoma. She has practiced at Robert Wood Johnson, Philadelphia's Wills Eye Hospital, and is also a fellow of the American Academy of Ophthalmology and a diplomat of the American Board of Ophthalmology. Keithanthony does creative visualization relaxation in the last hour of the show. www.blogtalkradio.com/caribbeanradioshow Call-In 1-661-467-2407

Host: Roy Levit, MD Guest: Julia Haller, MD Dr. Roy Levit welcomes Dr. Julia Haller to The Revealing Retina. Dr. Haller is President of the American Society of Retina Specialists and Chairman, Wills Eye Hospital, Philadelphia. Tune in to hear everything new in the treatment of macular degeneration.

Host: Roy Levit, MD Guest: Julia Haller, MD Dr. Roy Levit welcomes Dr. Julia Haller to The Revealing Retina. Dr. Haller is President of the American Society of Retina Specialists and Chairman, Wills Eye Hospital, Philadelphia. They will discuss the different types of macular degeneration, the demographics involved and who should be treating it.

Episode Recap:Dr. Lam and I talked aboutA day in the life of a retinal surgeon (1:27)How he finds time to write with a full-time job and four kids (6:13)His process for writing historical novels (8:17)How a history major became an eye surgeon (15:08)Why doctors don’t want their kids to become doctors (21:57)The luxury of a liberal arts degree (23:44)Balancing your dreams with practicality (30:19)Guest Bio:Andrew Lam, M.D., is the award-winning author of three books. Born in Philadelphia and raised in central Illinois, he graduated summa cum laude in history from Yale University, where he studied military history and U.S.-East Asian relations. He then attended medical school at the University of Pennsylvania, followed by specialty training in ophthalmology and retina surgery at the Wills Eye Hospital in Philadelphia. He is currently an Assistant Professor of Ophthalmology at the University of Massachusetts Medical School and Tufts University School of Medicine, a partner at New England Retina Consultants, and an attending surgeon at Baystate Medical Center in Springfield, Massachusetts.Links and Resources:Dr. Lam’s author websiteRepentance (available at Indiebound)Saving Sight (available at Barnes & Noble)Two Sons of China (available at Amazon)Stay in Touch:To suggest a guest or submit a question, Ask Auntie anything here: https://chiefexecutiveauntie.com/contact/ To join Auntie's podcast insiders and get special access to upcoming guests, subscribe here: https://chiefexecutiveauntie.com/podcast-insiders/Support this podcast at — https://redcircle.com/chief-executive-auntie/donations